NCT02181127
- Conditions
- Autoimmune Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 1, +8 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
Clinical trial condition
Diabetes Mellitus, Type 1
Explore clinical trials studying Diabetes Mellitus, Type 1. Study availability and eligibility vary by location and protocol.
2,861 public trials
319 recruiting studies
Diabetes Mellitus, Type 1 trial results
NCT02414958
- Conditions
- Autoimmune Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 1, +5 more
- Locations
-
- AMCR Institute, Inc. Escondido, California, United States
- Diabetes/Lipid Management and Research Center Huntington Beach, California, United States
- National Research Institute Los Angeles, California, United States
- Mills-Peninsula Health Services San Mateo, California, United States
NCT02034513
- Conditions
- Autoimmune Diseases, Diabetes, Diabetes Mellitus, +6 more
- Locations
-
- Novo Nordisk Investigational Site Birmingham, Alabama, United States
- Novo Nordisk Investigational Site Goodyear, Arizona, United States
- Novo Nordisk Investigational Site Concord, California, United States
- Novo Nordisk Investigational Site Escondido, California, United States
NCT03367351
- Conditions
- Autoimmune Diseases, Continuous Glucose Monitor, Diabetes Mellitus, +7 more
- Locations
-
- University of Florida Gainesville, Florida, United States
NCT02003677
- Conditions
- Autoimmune Diseases, Diabetes, Diabetes Mellitus, +6 more
- Locations
-
- Novo Nordisk Investigational Site Neuss, Germany
NCT02568280
- Conditions
- Autoimmune Diseases, Diabetes, Diabetes Mellitus, +6 more
- Locations
-
- Novo Nordisk Investigational Site Graz, Austria
NCT01696266
- Conditions
- Autoimmune Diseases, Diabetes, Diabetes Mellitus, +7 more
- Locations
-
- Novo Nordisk Investigational Site Prov. de Buenos Aires, Argentina
- Novo Nordisk Investigational Site Vienna, Austria
- Novo Nordisk Investigational Site Sofia, Bulgaria
- Novo Nordisk Investigational Site Mississauga, Canada
NCT01934712
- Conditions
- Autoimmune Diseases, Diabetes, Diabetes Mellitus, +6 more
- Locations
-
- Novo Nordisk Investigational Site Fukuoka, Japan
Completed
A Trial Investigating the Pharmacodynamic Properties of NN1218 in Subjects With Type 1 Diabetes
NCT01618188
- Conditions
- Autoimmune Diseases, Diabetes, Diabetes Mellitus, +6 more
- Locations
-
- Novo Nordisk Investigational Site Neuss, Germany
NCT03091673
- Conditions
- Autoimmune Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 1, +5 more
- Locations
-
- Stanford University Stanford, California, United States
- Barbara Davis Center for Childhood Diabetes Aurora, Colorado, United States
- Yale University New Haven, Connecticut, United States
- University of Florida Gainesville, Florida, United States